How scientific storytelling can help pharma cut through the noise

11 March 2022
doctor_communication_credit_depositphotos

An Expert View from Kristian Webb, scientific director of Page & Page and Partners.

For many in the pharmaceutical industry, hearing the word ‘storytelling’ in the context of their business might send shivers down their spines. The inference of tall tales, narratives and plots may feel a million miles away from the statistics, evidence and facts that underpin their drug development.

But rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut to understanding, which is a powerful tool, much needed at a time when there is so much pressure on our healthcare systems and we want patients to make good, informed choices as easily as possible.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical